Central Pontine Myelinolysis as a Late Complication After Hyponatremia and COVID-19 Infection
Osmotic demyelination syndrome (ODS) is a rare but serious condition that is hypothesized to be a result of rapid correction of hyponatremia, with a catastrophic prognosis. The foci of demyelination may occur in either the pontine area or within the white matter of the cerebral hemispheres, which de...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030256/ https://www.ncbi.nlm.nih.gov/pubmed/36960247 http://dx.doi.org/10.7759/cureus.35191 |
_version_ | 1784910318188625920 |
---|---|
author | Ivanova, Nora I Tsalta-Mladenov, Mihael E Georgieva, Darina K Andonova, Silva P |
author_facet | Ivanova, Nora I Tsalta-Mladenov, Mihael E Georgieva, Darina K Andonova, Silva P |
author_sort | Ivanova, Nora I |
collection | PubMed |
description | Osmotic demyelination syndrome (ODS) is a rare but serious condition that is hypothesized to be a result of rapid correction of hyponatremia, with a catastrophic prognosis. The foci of demyelination may occur in either the pontine area or within the white matter of the cerebral hemispheres, which denotes a specific clinical presentation. We present the case of a post-COVID-19 patient who was diagnosed with ODS with typical clinical and radiological characteristics of both forms: central pontine myelinolysis and extrapontine myelinolysis. The clinical assessment of ODS encompasses a variety of differential diagnoses, including stroke, neuroinfection, neoplasia, and other demyelinating diseases. A specific characteristic of ODS is the delayed clinical manifestation after the hyponatremic state. Furthermore, it is noteworthy that there might be discrepancies between the clinical manifestations and the neuroimaging findings. The association between COVID-19 and ODS is unclear at the moment, although it can possibly be explained by the viral infection through multiple mechanisms such as renal dysfunction, diarrhea, or vomiting. ODS should be considered in cases of hyponatremia and neurological deterioration during the course of COVID-19 infection. Despite the fact that early detection and treatment of this syndrome can reduce the risk of short-term mortality and long-term disability, they do not guarantee complete recovery. |
format | Online Article Text |
id | pubmed-10030256 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-100302562023-03-22 Central Pontine Myelinolysis as a Late Complication After Hyponatremia and COVID-19 Infection Ivanova, Nora I Tsalta-Mladenov, Mihael E Georgieva, Darina K Andonova, Silva P Cureus Family/General Practice Osmotic demyelination syndrome (ODS) is a rare but serious condition that is hypothesized to be a result of rapid correction of hyponatremia, with a catastrophic prognosis. The foci of demyelination may occur in either the pontine area or within the white matter of the cerebral hemispheres, which denotes a specific clinical presentation. We present the case of a post-COVID-19 patient who was diagnosed with ODS with typical clinical and radiological characteristics of both forms: central pontine myelinolysis and extrapontine myelinolysis. The clinical assessment of ODS encompasses a variety of differential diagnoses, including stroke, neuroinfection, neoplasia, and other demyelinating diseases. A specific characteristic of ODS is the delayed clinical manifestation after the hyponatremic state. Furthermore, it is noteworthy that there might be discrepancies between the clinical manifestations and the neuroimaging findings. The association between COVID-19 and ODS is unclear at the moment, although it can possibly be explained by the viral infection through multiple mechanisms such as renal dysfunction, diarrhea, or vomiting. ODS should be considered in cases of hyponatremia and neurological deterioration during the course of COVID-19 infection. Despite the fact that early detection and treatment of this syndrome can reduce the risk of short-term mortality and long-term disability, they do not guarantee complete recovery. Cureus 2023-02-19 /pmc/articles/PMC10030256/ /pubmed/36960247 http://dx.doi.org/10.7759/cureus.35191 Text en Copyright © 2023, Ivanova et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Family/General Practice Ivanova, Nora I Tsalta-Mladenov, Mihael E Georgieva, Darina K Andonova, Silva P Central Pontine Myelinolysis as a Late Complication After Hyponatremia and COVID-19 Infection |
title | Central Pontine Myelinolysis as a Late Complication After Hyponatremia and COVID-19 Infection |
title_full | Central Pontine Myelinolysis as a Late Complication After Hyponatremia and COVID-19 Infection |
title_fullStr | Central Pontine Myelinolysis as a Late Complication After Hyponatremia and COVID-19 Infection |
title_full_unstemmed | Central Pontine Myelinolysis as a Late Complication After Hyponatremia and COVID-19 Infection |
title_short | Central Pontine Myelinolysis as a Late Complication After Hyponatremia and COVID-19 Infection |
title_sort | central pontine myelinolysis as a late complication after hyponatremia and covid-19 infection |
topic | Family/General Practice |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030256/ https://www.ncbi.nlm.nih.gov/pubmed/36960247 http://dx.doi.org/10.7759/cureus.35191 |
work_keys_str_mv | AT ivanovanorai centralpontinemyelinolysisasalatecomplicationafterhyponatremiaandcovid19infection AT tsaltamladenovmihaele centralpontinemyelinolysisasalatecomplicationafterhyponatremiaandcovid19infection AT georgievadarinak centralpontinemyelinolysisasalatecomplicationafterhyponatremiaandcovid19infection AT andonovasilvap centralpontinemyelinolysisasalatecomplicationafterhyponatremiaandcovid19infection |